Prestige Wealth Management Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-136
Closed -$1.9K 1072
2023
Q3
$1.9K Buy
+136
New +$1.74K ﹤0.01% 751
2019
Q1
Sell
-51
Closed -$1K 1009
2018
Q4
$1K Buy
+51
New +$1.03K ﹤0.01% 1109

Other funds holding SBRA

Prestige Wealth Management Group's SBRA Position: Q4 2023 in Review

Prestige Wealth Management Group sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 136 shares — an estimated $1.9K sold.

Prestige Wealth Management Group first reported a position in SBRA in Q4 2018 and held it in 2 quarters. The position peaked at $1.9K in Q3 2023. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • Prestige Wealth Management Group reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • Prestige Wealth Management Group sold 136 Sabra Healthcare REIT shares in Q4 2023, an estimated $1.9K.
  • Prestige Wealth Management Group first reported a position in Sabra Healthcare REIT in Q4 2018 and held it in 2 quarters.
  • Prestige Wealth Management Group's Sabra Healthcare REIT position peaked at $1.9K in Q3 2023.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Prestige Wealth Management Group's 13F filing for Q4 2023, filed 8 Feb 2024.